135 related articles for article (PubMed ID: 28868014)
1. First-Line Treatment with Carboplatin plus
Funaishi K; Yamasaki M; Saito N; Daido W; Ishiyama S; Deguchi N; Taniwaki M; Ohashi N
Case Rep Oncol; 2017; 10(2):571-576. PubMed ID: 28868014
[TBL] [Abstract][Full Text] [Related]
2. Successful Treatment of Advanced Thymic Carcinoma with Carboplatin plus
Araya T; Kita T; Matsuoka H; Sakai T; Kimura H; Kasahara K
Case Rep Oncol; 2020; 13(3):1506-1512. PubMed ID: 33564291
[TBL] [Abstract][Full Text] [Related]
3. nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma.
Makimoto G; Fujiwara K; Watanabe H; Kameyama N; Matsushita M; Rai K; Sato K; Yonei T; Sato T; Shibayama T
Case Rep Oncol; 2014 Jan; 7(1):14-7. PubMed ID: 24575009
[TBL] [Abstract][Full Text] [Related]
4. Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
Manaka H; Igawa S; Yamamoto M; Oguri A; Manabe H; Kasajima M; Kusuhara S; Hosotani S; Nakahara Y; Sato T; Fukui T; Hisashi M; Sasaki J; Naoki K
Invest New Drugs; 2023 Feb; 41(1):115-121. PubMed ID: 36633784
[TBL] [Abstract][Full Text] [Related]
5. Response to chemotherapy with carboplatin plus albumin-bound paclitaxel in a patient with lymphoepithelioma-like thymic carcinoma: A case report.
Shima H; Ozasa H; Tsuji T; Ajimizu H; Nomizo T; Yagi Y; Sakamori Y; Nagai H; Minamiguchi S; Kim YH; Mishima M
Mol Clin Oncol; 2016 May; 4(5):715-718. PubMed ID: 27123268
[TBL] [Abstract][Full Text] [Related]
6. Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report.
Igawa S; Yanagisawa N; Niwa H; Ishihara M; Hiyoshi Y; Otani S; Katono K; Sasaki J; Satoh Y; Masuda N
Oncol Lett; 2015 Dec; 10(6):3519-3522. PubMed ID: 26788161
[TBL] [Abstract][Full Text] [Related]
7. The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias.
Fujita T; Hiroishi T; Shikano K; Yanagisawa A; Hayama N; Amano H; Nakamura M; Hirano S; Tabeta H; Nakamura S
Intern Med; 2018 Jul; 57(13):1827-1832. PubMed ID: 29434143
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of nab-paclitaxel and carboplatin chemotherapy plus necitumumab in the first-line treatment of patients with stage IV squamous non-small cell lung cancer.
Villaruz LC; Cobo M; Syrigos K; Mavroudis D; Zhang W; Kim JS; Socinski MA
Lung Cancer; 2019 Oct; 136():52-56. PubMed ID: 31445354
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of carboplatin plus nanoparticle albumin-bound paclitaxel after cisplatin plus pemetrexed in non-squamous non-small-cell lung cancer patients.
Tanaka M; Hattori Y; Ishii T; Tohnai R; Itoh S; Kawa Y; Kono Y; Urata Y; Satouchi M
Respir Investig; 2020 Jul; 58(4):269-274. PubMed ID: 32111518
[TBL] [Abstract][Full Text] [Related]
10. Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial.
Socinski MA; Bondarenko I; Karaseva NA; Makhson AM; Vynnychenko I; Okamoto I; Hon JK; Hirsh V; Bhar P; Zhang H; Iglesias JL; Renschler MF
J Clin Oncol; 2012 Jun; 30(17):2055-62. PubMed ID: 22547591
[TBL] [Abstract][Full Text] [Related]
11. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Akiyama N; Karayama M; Inui N; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inami N; Matsuura S; Kaida Y; Uto T; Matsui T; Asada K; Matsuda H; Fujii M; Toyoshima M; Suda T
Invest New Drugs; 2019 Jun; 37(3):531-537. PubMed ID: 30790149
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion.
Koyama N; Watanabe Y; Iwai Y; Miwa C; Nagai Y; Aoshiba K; Nakamura H
Neoplasma; 2018; 65(1):132-139. PubMed ID: 29322797
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer.
Huang L; Chen S; Yao L; Liu G; Wu J; Shao Z
Int J Nanomedicine; 2015; 10():1969-75. PubMed ID: 25792830
[TBL] [Abstract][Full Text] [Related]
14. Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients.
Bertino EM; Williams TM; Nana-Sinkam SP; Shilo K; Chatterjee M; Mo X; Rahmani M; Phillips GS; Villalona-Calero MA; Otterson GA
Clin Lung Cancer; 2015 Nov; 16(6):466-74. PubMed ID: 26123189
[TBL] [Abstract][Full Text] [Related]
15. Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer.
Blair HA; Deeks ED
Drugs; 2015 Nov; 75(17):2017-24. PubMed ID: 26541764
[TBL] [Abstract][Full Text] [Related]
16. [A case of thymic cancer effectively treated by weekly paclitaxel combined with carboplatin].
Kondo R; Watanabe S; Ishikawa D; Tanaka T; Ohshima Y; Asakawa K; Sakagami T; Okajima M; Miura S; Hayashi Y; Tanaka J; Kagamu H; Yoshizawa H; Narita I
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2607-9. PubMed ID: 25596057
[TBL] [Abstract][Full Text] [Related]
17. A dose finding study of weekly and every-3-week nab-Paclitaxel followed by carboplatin as first-line therapy in patients with advanced non-small cell lung cancer.
Socinski MA; Manikhas GM; Stroyakovsky DL; Makhson AN; Cheporov SV; Orlov SV; Yablonsky PK; Bhar P; Iglesias J
J Thorac Oncol; 2010 Jun; 5(6):852-61. PubMed ID: 20521351
[TBL] [Abstract][Full Text] [Related]
18. Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial.
Nakao A; Uchino J; Igata F; On R; Ikeda T; Yatsugi H; Hirano R; Sasaki T; Tanimura K; Imabayashi T; Tamiya N; Kaneko Y; Yamada T; Nagata N; Watanabe K; Kishimoto J; Takayama K; Fujita M
Invest New Drugs; 2018 Oct; 36(5):903-910. PubMed ID: 29846848
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of nanoparticle albumin-bound paclitaxel, carboplatin, and bevacizumab in first-line patients with advanced nonsquamous non-small cell lung cancer.
Reynolds C; Barrera D; Jotte R; Spira AI; Weissman C; Boehm KA; Pritchard S; Asmar L
J Thorac Oncol; 2009 Dec; 4(12):1537-43. PubMed ID: 19887966
[TBL] [Abstract][Full Text] [Related]
20. Real-World Evidence of Safety and Efficacy of Carboplatin plus Nanoparticle Albumin-Bound Paclitaxel in Patients with Advanced Non-Small-Cell Lung Cancer and Preexisting Interstitial Lung Disease: A Retrospective Study.
Araya T; Kita T; Ueda T; Terada N; Sakai T; Yamamura K; Kurokawa K; Uchida Y; Sone T; Kimura H; Kasahara K
Can Respir J; 2019; 2019():5315903. PubMed ID: 31015884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
